The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $114.70

Today's change0.00 0.00%
Updated January 18 4:03 PM EST. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $114.70

Today's change0.00 0.00%
Updated January 18 4:03 PM EST. Delayed by at least 15 minutes.

Johnson & Johnson closed at (U.S.)$114.70.

Over the last five days, shares are unchanged, but have gained 18.25% over the last 52 weeks. This security has underperformed the S&P 500 by 2.58% during the last year.

Key company metrics

  • Open(U.S.) $114.94
  • Previous close(U.S.) $114.70
  • High(U.S.) $115.10
  • Low(U.S.) $114.41
  • Bid / Ask-- / --
  • YTD % change-0.44%
  • Volume5,014,570
  • Average volume (10-day)5,973,690
  • Average volume (1-month)6,310,113
  • Average volume (3-month)6,875,675
  • 52-week range(U.S.) $94.28 to (U.S.) $126.07
  • Beta0.75
  • Trailing P/E20.10×
  • P/E 1 year forward17.10×
  • Forward PEG2.59×
  • Indicated annual dividend(U.S.) $3.20
  • Dividend yield2.79%
  • Trailing EPS(U.S.) $5.71
Updated January 18 4:03 PM EST. Delayed by at least 15 minutes.
S&P TSX0.28%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 02, 201610/02/2016Jul 03, 201607/03/2016Apr 03, 201604/03/2016Jan 03, 201601/03/2016
Revenue17,82018,48217,48217,811
Total other revenue--------
Total revenue17,82018,48217,48217,811
Gross profit12,35413,15312,17012,138
Total cost of revenue5,4665,3295,3125,673
Total operating expense12,55812,98512,22515,191
Selling / general / administrative4,7725,1764,6885,891
Research & development2,1792,2632,0132,865
Depreciation / amortization--------
Interest expense (income), net operating192190160160
Unusual expense (income)82150137723
Other operating expenses, total--------
Operating income5,2625,4975,2572,620
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5,2814,9045,2943,758
Income after tax4,2723,9974,4573,215
Income tax, total1,009907837543
Net income4,2723,9974,4573,215
Total adjustments to net income--------
Net income before extra. items4,2723,9974,4573,215
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4,2723,9974,4573,215
Inc. avail. to common incl. extra. items4,2723,9974,4573,215
Diluted net income4,2723,9974,4573,215
Dilution adjustment--------
Diluted weighted average shares2,7852,7942,7982,800
Diluted EPS excluding extraordinary itemsvalue per share1.531.431.591.15
Dividends per sharevalue per share0.800.800.750.75
Diluted normalized EPSvalue per share1.531.431.601.57